Science Explorer Back to mapMap

Most cited papers from Polyclinique de Franche Comté

What are the most cited papers from Polyclinique de Franche Comté?

The most cited paper from Polyclinique de Franche Comté is "Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials" (Alexa B. Kimball et al., 2023), with 332 citations. Next come "Stapled Hemorrhoidopexy Versus Milligan-Morgan Hemorrhoidectomy" (202) and "Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial" (167).

Showing 50 of 62 papers. Every paper with more than 6 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials Alexa B. Kimball et al. · The Lancet 3 Feb 2023 332
2 Stapled Hemorrhoidopexy Versus Milligan-Morgan Hemorrhoidectomy Jean François Gravié, Paul‐Antoine Lehur, N. Huten et al. · Annals of Surgery Open access 16 Jun 2005 202
3 Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial Jacobus Pfisterer et al. · The Lancet Oncology Open access187 authors 16 Apr 2020 167
4 Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort Thomas A. Walter et al. · European Journal of Cancer 11 May 2017 112
5 Genetic landscape of a large cohort of Primary Ovarian Insufficiency: New genes and pathways and implications for personalized medicine Abdelkader Heddar et al. · EBioMedicine Open access 10 Sep 2022 102
6 Correlation of HER2, FCGR2A, and FCGR3A gene polymorphisms with trastuzumab related cardiac toxicity and efficacy in a subgroup of patients from UNICANCER-PACS04 trial Lise Roca, Veronique C Dieras, Henri Hubert Roche et al. · Breast Cancer Research and Treatment Jun 2013 69
7 Development of scores assessing the refluxogenic potential of diet of patients with laryngopharyngeal reflux Jerome Rene Lechien et al. · European Archives of Oto-Rhino-Laryngology 12 Sep 2019 57
8 Relapse factors for ileal neuroendocrine tumours after curative surgery: A retrospective French multicentre study Catherine Le Roux, Catherine Lombard‐Bohas, Christelle Delmas et al. · Digestive and Liver Disease 19 Jun 2011 57
9 Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study Sophie Ng Wing Tin et al. · Orphanet Journal of Rare Diseases Open access Dec 2011 57
10 Adjuvant FOLFOX +/− cetuximab in fullRAS andBRAF wildtype stage III colon cancer patients Julien Taı̈eb, Ralyath Balogoun, Karine Le Malicot et al. · Annals of Oncology Open access 19 Dec 2016 53
11 Noninvasive Assessment of Cardiac Index in Healthy Volunteers: A Comparison Between Thoracic Impedance Cardiography and Doppler Echocardiography Jean-Luc Fellahi, Vincent Caille, Cyril Charron et al. · Anesthesia & Analgesia May 2009 51
12 Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX Jean‐François Emile et al. · European Journal of Cancer Open access340 authors 23 Jun 2017 48
13 Predictive factors of depressive symptoms of elderly patients with cancer receiving first-line chemotherapy Sébastien Duc, M. Rainfray, Pierre Soubeyran et al. · Psycho-Oncology 23 Feb 2016 45
14 Laparoscopic treatment of pancreatic pseudocysts Philippe Hauters, Joseph Weerts, Benoı̂t Navez et al. · Surgical Endoscopy 21 Aug 2004 41
15 Impact of everolimus blood concentration on its anti-cancer activity in patients with metastatic renal cell carcinoma Antoine Thiery-Vuillemin, Guillaume Mouillet, T. Nguyen Tan Hon et al. · Cancer Chemotherapy and Pharmacology 29 Mar 2014 35
16 Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma Stefano Chong Hun Kim et al. · Therapeutic Advances in Medical Oncology Open access 2020 34
17 Efficacy and safety of topical delgocitinib cream versus oral alitretinoin capsules in adults with severe chronic hand eczema (DELTA FORCE): a 24-week, randomised, head-to-head, phase 3 trial Ana Maria Gimenez-Arnau, Andreas Pinter, Wiebke Sondermann et al. · The Lancet 16 Apr 2025 31
18 Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer Valérie Boige et al. · JAMA Network Open Open access 18 Sep 2023 25
19 Summary version of the standards, options and recommendations for nonmetastatic breast cancer (updated January 2001) L. Mauriac et al. · British Journal of Cancer Open access Aug 2003 25
20 Evaluation of a 36 Gy elective node irradiation dose in anal cancer Alexis Lépinoy, Nicolas Lescut, Marc Puyraveau et al. · Radiotherapy and Oncology Aug 2015 25
21 Biologics in congenital ichthyosis: are they effective? J. Mazereeuw‐Hautier et al. · British Journal of Dermatology Open access 25 Oct 2024 24
22 Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study) Stefano Chong Hun Kim et al. · BMC Cancer Open access 25 Aug 2017 23
23 Five Year Results of the French EPI-ANA-01 Registry of AnacondaTM Endografts in the Treatment of Infrarenal Abdominal Aortic Aneurysms Dominique Midy et al. · European Journal of Vascular and Endovascular Surgery Open access 14 Mar 2020 22
24 Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 – REGOLD Thomas Aparicio et al. · Journal of Geriatric Oncology Open access 22 Apr 2020 21
25 Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial Thomas Aparicio et al. · Digestive and Liver Disease Open access 14 Sep 2022 20
26 Robot-assisted Partial Nephrectomy for Hilar and Nonhilar Renal Masses: Comparison of Perioperative, Oncological, and Functional Results in a Multicentre Prospective Cohort (NEPRAH Study, UroCCR 175) Julien Sarkis et al. · European Urology Oncology 26 Jun 2024 19
27 Oncocytoma on renal mass biopsy: is it still the same histology when surgery is performed? Results from UroCCR-104 study Nicolas Branger, Pierre Bigot, G. Pignot et al. · World Journal of Urology 12 Jan 2023 19
28 Transfusions and patient burden in chemotherapy-induced anaemia in France Patricia K. Corey‐Lisle, Marie‐Pierre Desrosiers, Helen Collins et al. · Therapeutic Advances in Medical Oncology Open access 22 May 2014 19
29 Woodworking injuries: A comparative study of work-related and hobby-related accidents François Loisel, Stephanie J. Bonin, Laurent Jeunet et al. · Chirurgie de la Main 10 Jul 2014 18
30 FOLFIRI® and Bevacizumab in first-line treatment for colorectal cancer patients: safety, efficacy and genetic polymorphisms Y. Bécouarn, Laurent Cany, Marina Pulido et al. · BMC Research Notes Open access 23 Apr 2014 17
31 Digital Necrosis and Lupus-Like Syndrome Preceeding Ovarian Carcinoma Maher Chtourou, François Aubin, I. Savariault et al. · Dermatology 1998 17
32 Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial Etienne G.C. Brain et al. · The Lancet Open access 31 Jul 2025 16
33 Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: week 104 results from the SUNSHINE and SUNRISE extension trial Alexa B. Kimball, Falk G. Bechara, Aysha Badat et al. · British Journal of Dermatology Open access 27 Nov 2024 16
34 Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer Adrien Grancher, Ludivine Beaussire, Sylvain Manfrédi et al. · Frontiers in Oncology Open access 10 Nov 2022 16
35 Hemoglobin levels and quality of life in patients with symptomatic chemotherapy-induced anemia: the eAQUA study Jean‐Loup Mouysset, Beata Freier, Joan van den Bosch et al. · Cancer Management and Research Open access 2016 16
36 Evolution of dupilumab‐associated conjunctivitis in patients with atopic dermatitis after switching dupilumab to tralokinumab or Janus kinase inhibitors ( RESO ‐ ADOC study) Ziad Reguiaï, Pierre André Becherel, Jean Luc Perrot et al. · Journal of the European Academy of Dermatology and Venereology Open access 17 Jul 2024 13
37 Evaluation of efficacy and safety of FOLFIRI for elderly patients with gastric cancer: A first-line phase II study Marianne Fonck, René Brunet, Y. Bécouarn et al. · Clinics and Research in Hepatology and Gastroenterology 10 Sep 2011 13
38 An unexpected case of Bartonella alsatica prosthetic vascular graft infection Mathilde Pugès, Armelle Ménard, Xavier Bérard et al. · Infection and Drug Resistance Open access Aug 2019 11
39 Lateral decubitus position for life-threatening postpneumonectomy pulmonary edema Jean-Christophe Farkas, Bruno Lafon, Michel Monteau et al. · Intensive Care Medicine 24 Oct 2006 11
40 Cementless total knee arthroplasty in chronic inflammatory rheumatism Jonathan Buchheit, Antoine Serre, Xavier Bouilloux et al. · European Journal of Orthopaedic Surgery & Traumatology 16 Sep 2013 11
41 Effectiveness and Safety of Tralokinumab in Atopic Dermatitis: 1-year Results From a Real-world Multicentre Study Laura Marina Calabrese, Élisa Cinotti, Martina D’Onghia et al. · Acta Dermato Venereologica Open access 12 Mar 2025 10
42 Impact of Baricitinib on Patients’ Quality of Life after One Year of Treatment for Atopic Dermatitis in Real-World Practice: Results of the Observatory of Chronic Inflammatory Skin Diseases Registry Ziad Reguiaï, Pierre André Becherel, Jean Luc Perrot et al. · Acta Dermato Venereologica Open access 6 Oct 2023 10
43 Efficacity of dupilumab in severe idiopathic cold urticaria: a case report Valentine Marchal, Z. Reguiaï · Journal of Dermatological Treatment Open access 17 Feb 2023 9
44 Transfemoral versus transcarotid access for transcatheter aortic valve replacement Maud-Emmanuelle Olivier, Alessandro Di Cesare, Anne Poncet et al. · JTCVS Techniques Open access 20 Jul 2022 9
45 398O Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer (CRC) - PRODIGE 13 a FFCD phase III trial Côme Lepage, Jean–Marc Phelip, Laurent Cany et al. · Annals of Oncology Open access Sep 2020 9
46 Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis Khaled Ezzedine, Anne Claire Fougerousse, Roberte Aubert et al. · Clinical Cosmetic and Investigational Dermatology Open access May 2020 9
47 Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients Éric Voog et al. · International Journal of Cancer Open access 18 Jul 2019 9
48 Validation du score visuel prostatique en images SVPI dans l’évaluation des symptômes du bas appareil urinaire associés à une hyperplasie bénigne de la prostate (550 patients) A. Descazeaud, Patrick J. Coloby, Jean‐Louis Davin et al. · The French Journal of Urology Mar 2017 9
49 ≪ Regards croisés 2009 ≫: enquête menée auprès de patients atteints de cancer et de professionnels de santé sur la perception de la fatigue et de l’anémie chimio-induite CHRISTOS CHOUAID, Philippe Colin, F. Maloisel et al. · ONCOLOGIE Mar 2010 9
50 Compared Burden of Psoriasis, Atopic Dermatitis, Hidradenitis Suppurativa, and Chronic Urticaria: Baseline Characteristics of the Patients Included in the OMCCI Cohort – A French, Prospective Multicenter Study of Chronic Inflammatory Dermatoses Pierre André Becherel et al. · Dermatology 17 Jul 2024 8

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.